(657)-214-3679
info@AscadaResearch.org
Therapeutic Clinical Trials
PFIZER
NCT05011513
An interventional efficacy and safety, phase 2/3, double-blind, 2-arm study to investigate orally administered XXXXXXXXX compared with placebo in non-hospitalized symptomatic adult participants with COVID-19 who are at low risk of progressing to severe illness
NCT04960202
An interventional efficacy and safety, phase 2/3, double-blind, 2-arm study to investigate orally administered XXXXXXXXX compared with placebo in non-hospitalized symptomatic adult participants with COVID-19 who are at increased risk of progressing to severe illness
NCT05047601
A phase 2/3, randomized, double-blind, double-dummy, placebo-controlled study to evaluate of 2 regimens of orally administered XXXXXXXXX in preventing symptomatic SARS-CoV-2 infection in adult household contacts of an individual with symptomatic COVID-19
JOHNS HOPKINS UNIVERSITY
NCT04373460
Convalescent Plasma to Limit Coronavirus Associated Complications: A Randomized, Double-Blind, Controlled, Phase 2 Study Comparing the Efficacy and Safety of Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 non-immune) Plasma Among Outpatients with Symptomatic COVID-19
GILEAD
NCT04539262
A Phase 1b/2a Study in Participants with Early Stage COVID-19 to Evaluate the Safety, Efficacy, and Pharmacokinetics of XXXXXXXXXX Administered by Inhalation
NCT04501952
A Phase 3 Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of XXXXXXXXXXX Treatment of COVID-19 in an Outpatient Setting
MOLECULAR PARTNERS AG
NCT04828161
A randomized, double-blind, placebo-controlled, multicenter study of XXXXXXXXX in ambulatory adult patients with symptomatic COVID-19
PARDES BIOSCIENCES
NCT05543707
A Phase 2 Double-blind, Randomized Study to Evaluate the Antiviral Activity, Safety, and Efficacy of Orally Administered XXXXXXX Compared with Placebo in Non-hospitalized Symptomatic Adults with COVID-19
MERCK SHARP & DOHME
NCT04939428
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of XXXXXX for the Prevention of COVID-19 (Laboratory-confirmed SARS-CoV-2 Infection With Symptoms) in Adults Residing With a Person With COVID-19.
In-Vitro Diagnostic and Biospecimen Collection Clinical Trials
ALERE (ABBOTT)
Prospective Specimen Collection from Self-reported Drug Users for the Design and Development of ARDx Drugs of Abuse Assays
FREENOME
NCT03688906
Prospective Blood Sample Collection Study for Product Development in Detecting Colorectal Cancer and Advanced Adenomas
PROGNOMIQ
A Prospective Blood Sample Collection Study to Evaluate a Panel of Protein-based Biomarkers
ADAPTIVE BIOTECHNOLOGIES
NCT05054088
Study to assess the clinical performance of the T-DetectTM COVID test to identify an immune response to SARS-CoV-2 infection in the setting of multiple circulating variants of the SARS-CoV-2 virus
iHEALTH LABS INC.
Evaluation of a iHealth COVID-19 Ag Card for SARS-CoV-2 Detection in COVID-19 Symptomatic Individuals
Evaluation of a iHealth COVID-19 Ag Home Test Kit for SARS-CoD-2 Detection in COVID-19 Symptomatic and Asymptomatic Individuals
AMPLIFIDX INC.
Collection and Distribution of Anterior Nares Swab Specimens to Assist in Development of Diagnostic Assays for COVID-19
SA SCIENTIFIC LTD.
Study to Evaluate the Performance of the SASTM At Home COVID-19 AG Test Kit
RESEARCHDX INC.
Prospective Sample Collection for the Clinical Evaluation of Credo VitaPCRTM Respiratory Panel Assays
IPROCESS GLOBAL RESEARCH INC.
Collection of SARS-CoV-2, Influenza A, and Influenza B Positive Respiratory Swabs to Support Clinical Validation Studies for Diagnostic Kits.
CHEMBIO DIAGNOSTIC SYSTEMS INC.
Prospective Testing of Samples for COVID-19 Testing at the Point of Care
CANTOR BIOCONNECT
Prospective Sample Collection of SARS-CoV-2 Nasopharyngeal Swabs in Symptomatic Positive Individuals
Prospective Sample Collection of Influenza A and Influenza B Nasopharyngeal Swabs
Prospective Sample Collection of SARS-CoV-2 Nasopharyngeal Swabs in Asymptomatic Positive Individuals
Covid-19 Biological Material Collection for Clinical Device Evaluation
SORRENTO THERAPEUTICS
COVISTIXTM in Vitra Diagnostic Validation Clinical Performance Study of Nasal RT-PCR vs. Nasal COVISTIX for At-Home Use
GENERAL BIOLOGICALS CORPORATION
GB COVID-19 Ag Point of Care Test Clinical Validation Plan
OCEANIT
Clinical Evaluation of ASSURE-100 Rrapid COVID-19 Home Test vs. RT-PCR Using Natural Clinical Nasal Swabs Specimens from Suspected COVID-19 Donors
Randomized, Double-blind Prospective Observational Cohort Study of Volunteer Participants That Will Assess the Sensitivity, Specificity, and Usability of a Consumer Test Kit in Detecting SARS-CoV-2 in Symptomatic Individuals Compared to a Commercially Available RT-PCR Assay Kit
TANGEN
A Multicenter Study Conducted to Evaluate the Performance of the TangenDx System for COVID-19 in Point of Care Locations
FUJIREBIO
Prospective Sample Collection of SARS-CoV-2 Nasopharyngeal Swabs in Symptomatic Positive Individuals
Device Trials
ACON
The ACON hCG Pregnancy Test is a device for the qualitative detection of human chorionic gonadotropin (hCG) in urine to aid in the early detection of pregnancy. To determine if the ACON hCG Pregnancy Test can be performed correctly by laypersons, and if results obtained by laypersons are substantially equivalent to results obtained by trained professional operators.
MASIMO
Data Collection for the Masimo Automated Noninvasive Blood Pressure (NIBP) Device in Pediatric Populations
Data Collection for Masimo Thermometry Devices in Afebrile Pediatric and Adult Subjects